Skip to main content
. Author manuscript; available in PMC: 2022 May 11.
Published in final edited form as: J Alzheimers Dis. 2021;83(3):1379–1389. doi: 10.3233/JAD-210588

Table 3.

Model for association of CESD-10 TWAs with composite cognitive function outcome with inclusion of each life course stage age, sex, race, cohort, and anti-depressant use as predictors (45,811 observations, 6,122 [3,930 CHS, 2,192 HABC] participants)

Early Adulthood β (95% CI) Mid-life β (95% CI) Late-life β (95% CI)

Difference in cognition at age 80 versus CESD-10 low (0–3) scores

CESD-10
 Moderate (4–10) 0.01 (−0.06, 0.08) −0.04 (−0.09, 0.02) −0.10 (−0.12, −0.07)
 High (10+) NA* −0.28 (−0.55, −0.01) −0.15 (−0.21, −0.10)

Difference in 10-year change in cognition versus CESD-10 low (0–3) scores

CESD-10
 Moderate (4–10) −0.07 (−0.13, −0.01) 0.08 (0.03,0.13) −0.17 (−0.20, −0.14)
 High (10+) NA* −0.07 (−0.29, 0.16) −0.26 (−0.33, −0.20)

Composite defined as average of Z-scores for DSST and −log(101-3MS).